The estimated Net Worth of Javan Esfandiari is at least 1.28 百万$ dollars as of 8 October 2021. Mr Esfandiari owns over 73,806 units of Chembio Diagnostics stock worth over 69,121$ and over the last 17 years he sold CEMI stock worth over 649,200$. In addition, he makes 557,521$ as Exec. VP and Chief Science & Technology Officer at Chembio Diagnostics.
Mr has made over 10 trades of the Chembio Diagnostics stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 73,806 units of CEMI stock worth 33,951$ on 8 October 2021.
The largest trade he's ever made was selling 80,000 units of Chembio Diagnostics stock on 7 December 2011 worth over 32,000$. On average, Mr trades about 9,902 units every 117 days since 2008. As of 8 October 2021 he still owns at least 150,264 units of Chembio Diagnostics stock.
You can see the complete history of Mr Esfandiari stock trades at the bottom of the page.
Javan Esfandiari is the Exec. VP and Chief Science & Technology Officer at Chembio Diagnostics.
As the Exec. VP and Chief Science & Technology Officer of Chembio Diagnostics, the total compensation of Mr Esfandiari at Chembio Diagnostics is 557,521$. There are no executives at Chembio Diagnostics getting paid more.
Mr Esfandiari is 54, he's been the Exec. VP and Chief Science & Technology Officer of Chembio Diagnostics since . There are 5 older and 2 younger executives at Chembio Diagnostics. The oldest executive at Chembio Diagnostics Inc. is Mary Polan, 76, who is the Independent Director.
Javan's mailing address filed with the SEC is C/O CHEMBIO DIAGNOSTICS, INC., 3661 HORSEBLOCK ROAD, MEDFORD, NY, 11763.
Over the last 20 years, insiders at Chembio Diagnostics have traded over 909,824$ worth of Chembio Diagnostics stock and bought 3,754,893 units worth 1,696,058$ . The most active insiders traders include Credit Advisors, Llcpercept...、Lawrence A. Siebert、Richard Eberly. On average, Chembio Diagnostics executives and independent directors trade stock every 90 days with the average trade being worth of 36,203$. The most recent stock trade was executed by Credit Advisors, Llcpercept... on 21 April 2023, trading 243,448 units of CEMI stock currently worth 109,552$.
Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.
Chembio Diagnostics executives and other stock owners filed with the SEC include: